Funding Opportunities and Deadlines

Research Priority

Beta Cell Regeneration and Survival

Letter of Intent Due

February 07

Discovery and Development of Strategies for Targeted Drug Delivery to Human Islets for T1D

Details

Milestone Date Status
Letter of Intent Feb 07, 2020 Next
Application Mar 20, 2020
Award Notification Jul 31, 2020
Earliest Start Sep 01, 2020
Complications

Application Due
(Letter of Intent Required)

January 27

Novel Therapeutic Strategies to Prevent or Delay Progression of Early Stage Diabetic Nephropathy

Details

Milestone Date Status
Letter of Intent Required Dec 10, 2019 Passed
Application Jan 27, 2020 Next
Award Notification Jul 31, 2020
Earliest Start Sep 30, 2020

Ongoing Opportunities

These funding sources are typically available annually or ongoing

JDRF Impact Grants

Conference Grants

Industry Discovery & Development Partnerships

Early-Career Patient-Oriented Diabetes Research Awards (projects in COMPLICATIONS are ineligible)
Jan 31

Career Development Awards (projects in COMPLICATIONS are ineligible)
Jan 31

Advanced Postdoctoral Fellowships (projects in COMPLICATIONS are ineligible)
Jan 31

Postdoctoral Fellowships (projects in COMPLICATIONS are ineligible)
Jan 31

Project Concepts (Strategic Research Agreement)
Feb 03

RFAs Awaiting Notification

Jan

Beta Cell Replacement Innovative Awards
Jan

Metabolic Control Innovative Awards
Jan

Immunotherapies Innovative Awards
Feb

Validation of T Cell Biomarkers and Assays for T1D
Mar

Telehealth in Type 1 Diabetes Behavioral Health and Psychology
Mar

Optimization and Clinical Validation of Islet Autoantibody Assays for Screening for Type One Diabetes Risk
Mar

Repositioning Drugs to Improve Metabolic Control in Established Type 1 Diabetes
Mar

Therapeutic Development and Clinical Testing of Immune Therapies for Type 1 Diabetes
Apr

The Role of the Microbiome in Type 1 Diabetes: Pathogenesis and Therapeutic Utility
Apr

3D Bioprinting and Biofabrication of Rationally Designed Engineered Tissue Constructs as Therapeutic Products for Treatment of Type 1 Diabetes (T1D)
May

JDRF Diabetes Psychology Postdoctoral Fellowship Program
May

Novel Therapeutic Strategies to Prevent or Delay Progression of Early Stage Diabetic Retinopathy
May

Safe and Effective Use of SGLT Inhibitors for Type 1 Diabetes
May

Decoding Immune Mediated Diseases – Novel Approaches for Therapeutic Insights